If any acceptor shows symptoms and/or signs thromboembolic disorder, the continuation of using Andalan should be reevaluated .
Any acceptor who develops an acute impairment of vision, proptosis, diplopia, migraine should be evaluated to exclude papilledema or retinal vascular lesions before continuing treatment.
During pregnancy, usage of Andalan is contraindicated. It is not suggested to use Andalan as a pregnancy test or to end a pregnancy.
After administration of Andalan for several times, amenorrhea and anovulation may persist for periods up to 18 months, in rare cases for longer periods.
In some cases anaphylactic and anaphylactoid reactions have occasionally been reported.